Shelcel Biozeen Technologies, an Indian company, has been awarded a $1.8 million UNDP contract to supply fermentation modules to Cuba's biopharmaceutical sector.
03 Nov 2025
Cuba - 24 October 2025, Shelcel Biozeen Technologies Private Limited has been awarded a USD 1,812,865 contract by the United Nations Development Programme (UNDP) to supply and install a fermentation module for Cuba's biopharmaceutical industry. The agreement, which was signed on October 24, 2025, is a component of UNDP's continuous initiatives to support technology-driven health innovation and bolster Cuba's domestic pharmaceutical manufacturing capacity.Project SynopsisProviding an advanced fermentation system for the biopharmaceutical industry (Sistema de Fermentadores para la Industria Biofarmacéutica) is the main goal of the awarded project, "Módulo de Fermentadores." The module will help Cuba's well-known biotech industry grow its production capacity by being utilised for bioprocess development, vaccine manufacturing, and active pharmaceutical ingredient (API) synthesis.Specifics of the Contract Title of Project: Fermentator Módulo The number of references is 10432138/UNDP-CUB-00260,1. The United Nations Development Programme (UNDP) in Cuba is the contracting authority. Shelcel Biozeen Technologies Private Limited is the supplier. Value of Contract: $1,812,865 USD Date of Award: October 24, 2025 Method of Procurement: UNDP Bid Invitation Organisations Taking PartUNDP Cuba, which oversees the project, is a major contributor to Cuba's efforts at industrial and scientific modernisation. Shelcel Biozeen Technologies Pvt. Ltd., the successful bidder, is a biotechnology equipment manufacturer with headquarters in India and a reputation for proficiency in cleanroom solutions, fermentation, and bioprocessing. The business has provided comparable biotechnological systems to a number of global pharmaceutical organisations and research and development facilities.Importance of the AgreementCuba's bioinnovation and vaccine production programmes, which are known throughout the world for their high calibre and durability, will benefit strategically from this investment. It is anticipated that the installation of a cutting-edge fermentation module will improve national biotechnology institutes' capacity for research, process control, and production efficiency.The project strengthens ties between Cuba and India in the areas of scientific and industrial development by utilising UNDP's transparent procurement system to guarantee the delivery of high-quality equipment and to promote South-South cooperation.Economic and Strategic EffectsIn order to ensure pharmaceutical production self-sufficiency, lessen reliance on imports, and promote innovation in biotherapeutics and vaccine manufacturing, modernising Cuba's fermentation infrastructure is essential. It supports the UNDP's overarching goal of promoting technology-based, inclusive, and sustainable development in emerging economies.To sum up:For Cuba's biopharmaceutical sector, the UNDP-Shelcel Biozeen Technologies collaboration represents a significant breakthrough. Cuba is well-positioned to increase its research output, production capacity, and export potential in the global biotechnology arena with the installation of the new fermentation module, solidifying its standing as a regional leader in scientific excellence and health innovation. Tags:#Cuba, #UNDP, #Shelcel Biozeen Technologies, #biotechnology, #Fermentation Systems, #biopharmaceutical industry, #vaccine production, #procurement news, #Tender Results, #Contract Award #government contracts, UNDP Cuba, #Public procurement, #life sciences infrastructure, #South-South cooperation
Read More